Top 14 Life Science companies in Stockholm, Stockholms Lan, Sweden
Meet the trailblazing entities significantly contributing to the growth and evolution of this sector.
Emtora Biosciences is a life science company that commercializes a new formulation of an immunosuppressant as a prostate cancer drug. The company developing a novel formulation of rapamycin, eRapa for use in preventing the onset and recurrence of cancer. It manufactures a drug to slow the aging process and its efficacy in treating age-related diseases. The eRapa is the only pharmaceutical agent to demonstrate significantly increased healthspan and lifespan in rodent models, and Science, Nature, and Time magazines proclaimed the discovery of a special formulation of rapamycin to extend one’s life and health span among the most significant and exciting scientific breakthroughs of 2009.
Sam S Miller MD provides medical care that is targeted to the individual's needs, including treatment and lifestyle recommendations. They apply their expertise in internal medicine and endocrinology, and years of experience, to patients as patients, giving them the time, attention, and information needed for medical care. The innovative clinical research being undertaken at science advancing medicine clinical research center complements the medical treatment that provides in private practice.
Biomedical Enterprises Inc. (BME) was founded to research, develop and commercialize medical products. BME's first product, an innovative dialysis needle (the BME needle), reduces patient complications resulting from hemodialysis, thereby increasing revenue for dialysis clinics and reducing cost for medical insurers. The BME needle provides a solution to the number one problem plaguing dialysis clinics, dialysis patients and insurers - clotting and occlusion of the vascular access. In addition, the BME needle appears to reduce inflammation and oxidative stress which also decrease the occurrence of medical complications. The company is raising funds to commercialize the needle and in the process of obtaining government approval for commercialization. The company has obtained about $1.0 million in grants from the U.S. National Institute of Health for R&D.
INCELL Corporation offers product manufacturing and contract services with innovative life science solutions in biomedicine. They manufacture and develop effective treatments for unmet medical needs of family and to be recognized for high quality, substantive science, integrity and ethics in making products and providing services that accelerate time-to-market. They embody the spirit of the company to serve humanity and help improve quality of life, value its worldwide patients, customers, and partners, inspire a workplace that fosters personal and professional growth, and outstanding corporate and community citizens.
InCube Labs is a life sciences research lab focused on developing medical breakthroughs that dramatically improve patient outcomes. Their multi-disciplinary approach integrates traditional device technologies such as electronics, software, mechanical engineering and material science, with innovations from the pharmaceutical industry, often involving protein chemistry, pharmacology and cell biology. InCube is led by Mir Imran, an accomplished medical innovator, entrepreneur and venture capitalist, who has founded more than 20 life sciences companies and holds more than 200 patents. Many of Imran’s innovations have resulted in new standards of care, including the first FDA-approved Automatic Implantable Cardioverter Defibrillator.
Eagle Global Scientific is a life science company composed of diverse leadership, partners, and employees who share a passion for the interplay between medical, biological, and environmental sciences. They offer services for infectious diseases, advanced diagnostics, public health emergency response, public health communication, regenerative medicine, military medical research, precision medicine, and virtual health.
Probetex offers products and services for evaluating experimental illnesses. They offer tools for the study of disease, which is frequently a deciding factor for individuals looking to gather preliminary or conclusive data for publications, grant applications, drug discovery, the pathobiology of disease, or feasibility studies. They offer contract drug discovery services using organ and kidney disease models. They also offer renal function testing, tissue preparation for embedding in paraffin and staining, frozen tissue for immunohistochemistry, image analysis, and tissue lysates for analysis.